In vitro screening for antibacterial activity against public health disease pathogens
Ended Awarded
- Contract number
- 75N93022F00001
- Awardee
-
Element Materials Technology Iowa City Inc. UEI GAJDDSFFPD89
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $103,000
Award facts
- Contract value 53% obligated
-
- $103,000.00 Current, with exercised options
- $195,700.00 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 5 offers Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- North Liberty, IA 52317, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
About this award
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $195.7K delivery order to Element Materials Technology Iowa City Inc., operating as JMI Laboratories, for in vitro screening of antibacterial activity against public health disease pathogens. The contract, which was awarded on April 21, 2022, with an ultimate completion date of May 1, 2023, is structured as a firm fixed-price delivery order under the In Vitro Assessments of Antimicrobial Activity (IVAAA) indefinite-delivery/indefinite-quantity contract vehicle. The work will be performed in North Liberty, Iowa, and does not utilize a set-aside designation.
JMI Laboratories is a microbiology specialist firm registered to receive federal contract awards since 2016 that provides antimicrobial resistance testing and research services to multiple HHS agencies, including NIAID, the Food and Drug Administration, and the National Institutes of Health. The company specializes in conducting in vitro assessments of antimicrobial activity, minimum inhibitory concentration assays, and antimicrobial resistance research, with particular expertise in evaluating experimental antibacterial substances against bacterial pathogens and analyzing emerging resistance trends. This engagement represents part of the company's ongoing support for critical public health initiatives addressing antimicrobial resistance through the IVAAA contract vehicle.
Quick answers
Who was awarded contract 75N93022F00001?
75N93022F00001 was awarded to Element Materials Technology Iowa City Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on April 21, 2022.
How much is contract 75N93022F00001 worth?
The government has obligated $103,000 on 75N93022F00001. Its potential value, with all options, is $195,700.
Is contract 75N93022F00001 an order under another contract?
Yes. 75N93022F00001 is a delivery order under 75N93019D00011, an indefinite delivery contract, on In Vitro Assessments of Antimicrobial Activity (IVAAA).
Was contract 75N93022F00001 competed?
The extent of competition for 75N93022F00001 was full and open competition. The government received 5 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award